Next Article in Journal
C-Reactive Protein Monitoring and Clinical Presentation of Fever as Predictive Factors of Prolonged Febrile Neutropenia and Blood Culture Positivity after Autologous Hematopoietic Stem Cell Transplantation—Single-Center Real-Life Experience
Next Article in Special Issue
Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer
Previous Article in Journal
Post-Ureteroscopy Infections Are Linked to Pre-Operative Stent Dwell Time over Two Months: Outcomes of Three European Endourology Centres
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 11
Issue 2
10.3390/jcm11020311
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

New Horizons for Personalised Treatment in Gastroesophageal Cancer

by
Massimiliano Salati
1,2,* and
Andrea Spallanzani
1
1
Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy
2
PhD Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(2), 311; https://doi.org/10.3390/jcm11020311
Submission received: 23 December 2021 / Accepted: 29 December 2021 / Published: 9 January 2022
(This article belongs to the Special Issue Novel Therapeutic Approaches for Gastroesophageal Cancer)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Gastric and gastroesophageal junction adenocarcinoma (GEA) is still responsible for a huge health burden worldwide, being the second most common cause of cancer-related death globally [...]

Share and Cite

MDPI and ACS Style

Salati, M.; Spallanzani, A. New Horizons for Personalised Treatment in Gastroesophageal Cancer. J. Clin. Med. 2022, 11, 311. https://doi.org/10.3390/jcm11020311

AMA Style

Salati M, Spallanzani A. New Horizons for Personalised Treatment in Gastroesophageal Cancer. Journal of Clinical Medicine. 2022; 11(2):311. https://doi.org/10.3390/jcm11020311

Chicago/Turabian Style

Salati, Massimiliano, and Andrea Spallanzani. 2022. "New Horizons for Personalised Treatment in Gastroesophageal Cancer" Journal of Clinical Medicine 11, no. 2: 311. https://doi.org/10.3390/jcm11020311

APA Style

Salati, M., & Spallanzani, A. (2022). New Horizons for Personalised Treatment in Gastroesophageal Cancer. Journal of Clinical Medicine, 11(2), 311. https://doi.org/10.3390/jcm11020311

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop